|
| ID | Pathway | Genes | Number of genes |
|
| hsa05167 | Kaposi sarcoma-associated herpesvirus infection | GSK3B/CASP9/CASP3/CASP8/RELA/CCND1/IL6/VEGFA/FOS/HIF1A/CYCS/RB1/NFKBIA/ICAM1/RAF1/MYC | 16 |
| hsa05163 | Human cytomegalovirus infection | GSK3B/CASP9/CASP3/CASP8/PRKCA/RELA/CCND1/IL6/VEGFA/CYCS/EGFR/RB1/NFKBIA/MDM2/RAF1/MYC | 16 |
| hsa05161 | Hepatitis B | BCL2/CASP9/CASP3/CASP8/PRKCA/RELA/IL6/FOS/CYCS/RB1/NFKBIA/PCNA/BIRC5/RAF1/MYC | 15 |
| hsa05206 | MicroRNAs in cancer | BCL2/CASP3/PRKCA/PLAU/CCND1/TP63/MCL1/VEGFA/EGFR/MDM2/ERBB2/RAF1/MYC/CYP1B1/RASSF1 | 15 |
| hsa04151 | PI3K-Akt signaling pathway | GSK3B/BCL2/CASP9/PRKCA/RELA/CCND1/IL6/MCL1/VEGFA/IGF2/EGFR/MDM2/ERBB2/RAF1/MYC | 15 |
| hsa04210 | Apoptosis | BCL2/CASP9/CASP3/CASP8/RELA/MCL1/FOS/CYCS/NFKBIA/CASP7/BIRC5/RAF1/PARP1/CTSD | 14 |
| hsa05205 | Proteoglycans in cancer | ESR1/CASP3/PRKCA/PLAU/CCND1/VEGFA/HIF1A/IGF2/EGFR/MDM2/ERBB2/RAF1/CAV1/MYC | 14 |
| hsa05215 | Prostate cancer | GSK3B/BCL2/CASP9/PLAU/RELA/CCND1/EGFR/RB1/NFKBIA/MDM2/ERBB2/GSTP1/RAF1 | 13 |
| hsa05169 | Epstein-Barr virus infection | BCL2/CASP9/CASP3/CASP8/RELA/CCND1/IL6/CYCS/RB1/NFKBIA/MDM2/ICAM1/MYC | 13 |
| hsa05160 | Hepatitis C | GSK3B/CASP9/CASP3/CASP8/RELA/CCND1/CYCS/EGFR/RB1/NFKBIA/RAF1/MYC | 12 |
| hsa05170 | Human immunodeficiency virus 1 infection | CHEK1/BCL2/CASP9/CASP3/CASP8/PRKCA/RELA/FOS/CCNB1/CYCS/NFKBIA/RAF1 | 12 |
| hsa04010 | MAPK signaling pathway | CASP3/PRKCA/RELA/VEGFA/FOS/IGF2/EGFR/ERBB2/RAF1/MYC/HSPB1/RASA1 | 12 |
| hsa04115 | p53 signaling pathway | CHEK1/BCL2/CASP9/CASP3/CASP8/CCND1/CCNB1/CYCS/MDM2/CHEK2/IGFBP3 | 11 |
| hsa05210 | Colorectal cancer | GSK3B/BCL2/CASP9/CASP3/CCND1/FOS/CYCS/EGFR/BIRC5/RAF1/MYC | 11 |
| hsa05162 | Measles | GSK3B/BCL2/CASP9/CASP3/CASP8/RELA/CCND1/IL6/FOS/CYCS/NFKBIA | 11 |
| hsa04218 | Cellular senescence | CHEK1/RELA/CCND1/IL6/CCNB1/RB1/MDM2/RAF1/MYC/CHEK2/IGFBP3 | 11 |
| hsa05225 | Hepatocellular carcinoma | GSK3B/PRKCA/CCND1/IGF2/NQO1/EGFR/RB1/GSTP1/RAF1/MYC/GSTM1 | 11 |
| hsa05166 | Human T cell leukemia virus 1 infection | CHEK1/RELA/CCND1/IL6/FOS/FOSL1/RB1/NFKBIA/ICAM1/MYC/CHEK2 | 11 |
| hsa05132 | Salmonella infection | BCL2/CASP3/CASP8/RELA/IL6/FOS/CYCS/NFKBIA/CASP7/RAF1/MYC | 11 |
| hsa05165 | Human papillomavirus infection | GSK3B/CASP3/CASP8/RELA/CCND1/VEGFA/EGFR/RB1/MDM2/RAF1/IRF1 | 11 |
| hsa05022 | Pathways of neurodegeneration, multiple diseases | GSK3B/BCL2/CASP9/CASP3/CASP8/PRKCA/RELA/IL6/CYCS/CASP7/RAF1 | 11 |
| hsa01524 | Platinum drug resistance | BCL2/CASP9/CASP3/CASP8/CYCS/MDM2/ERBB2/BIRC5/GSTP1/GSTM1 | 10 |
| hsa05224 | Breast cancer | ESR1/PGR/GSK3B/CCND1/FOS/EGFR/RB1/ERBB2/RAF1/MYC | 10 |
| hsa05164 | Influenza A | CASP9/CASP3/CASP8/PRKCA/RELA/IL6/CYCS/NFKBIA/ICAM1/RAF1 | 10 |
| hsa05167 | Kaposi sarcoma-associated herpesvirus infection | GSK3B/CASP9/CASP3/CASP8/RELA/CCND1/IL6/VEGFA/FOS/HIF1A/CYCS/RB1/NFKBIA/ICAM1/RAF1/MYC | 16 |
| hsa05163 | Human cytomegalovirus infection | GSK3B/CASP9/CASP3/CASP8/PRKCA/RELA/CCND1/IL6/VEGFA/CYCS/EGFR/RB1/NFKBIA/MDM2/RAF1/MYC | 16 |
| hsa05161 | Hepatitis B | BCL2/CASP9/CASP3/CASP8/PRKCA/RELA/IL6/FOS/CYCS/RB1/NFKBIA/PCNA/BIRC5/RAF1/MYC | 15 |
| hsa05206 | MicroRNAs in cancer | BCL2/CASP3/PRKCA/PLAU/CCND1/TP63/MCL1/VEGFA/EGFR/MDM2/ERBB2/RAF1/MYC/CYP1B1/RASSF1 | 15 |
| hsa04151 | PI3K-Akt signaling pathway | GSK3B/BCL2/CASP9/PRKCA/RELA/CCND1/IL6/MCL1/VEGFA/IGF2/EGFR/MDM2/ERBB2/RAF1/MYC | 15 |
|
